Your session is about to expire
← Back to Search
Experimental Hypoglycemia for Type 1 Diabetes
Study Summary
This trial will explore why some type 1 diabetics have impaired awareness of hypoglycemia after exposure to recurrent hypoglycemia, by measuring neurochemical profiles before and after induction of IAH.
- Type 1 Diabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the eligibility for this clinical study limited to those over 20 years of age?
"Eligibility for this medical trial is limited to patients aged 18-65. However, there are aplenty of other studies dedicated to below 18 and above 65 year old individuals; 224 and 944 respectively."
How many individuals are currently receiving treatment in this trial?
"Affirmative. Clinicaltrials.gov displays evidence that this research is currently seeking to recruit patients, with an original posting date of May 24th 2018 and a recent update on September 16th 2022. The project requires 50 participants from 1 site."
Am I qualified to take part in this medical research?
"Patient eligibility for this trial necessitates a diagnosis of diabetes, an autoimmune condition, and being between the age limits of 18 to 65. The current goal is to enrol 50 individuals in total."
Are there still vacancies to partake in this experiment?
"Indeed, clinicaltrials.gov indicates that this trial is in the process of seeking volunteers. The initial post was made on May 24th 2018 and it was last updated September 16th 2022. Approximately 50 individuals are being sought from 1 medical centre."
Share this study with friends
Copy Link
Messenger